Skip to content

Imaging Speech in Neurotypical Adults and Individuals With Cerebellar Stroke

High-resolution Functional Imaging of Speech-induced Sensory Modulation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06458153
Enrollment
100
Registered
2024-06-13
Start date
2025-05-27
Completion date
2028-07-01
Last updated
2026-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebellum, Stroke

Keywords

fmri, speech production, cerebellum, auditory-motor integration, speech motor control, neuroimaging

Brief summary

The goal of this research study is to learn how the brain areas that plan and control movement interact with the areas responsible for hearing and perceiving speech in healthy adults and people who have had cerebellar strokes. The main questions it aims to answer are: 1. What regions of the brain's sensory systems show changes in their activity related to speech? 2. To what extent do these regions help listeners detect and correct speech errors? 3. What is the role of the cerebellum (a part of the brain in the back of the head) in these activities? Participants will be asked to complete several experimental sessions involving behavioral speech and related tests and non-invasive brain imaging using electroencephalography (EEG) and functional magnetic resonance imaging (fMRI).

Detailed description

This study aims to provide an integrated view of brain systems underlying predictive coding in speech with unprecedented detail using ultra-high field (7 Tesla) functional magnetic resonance imaging. The overall approach is a condition-intensive within-subjects design, with extensive sampling of individual participants, including a group who have had strokes impacting the cerebellum, across multiple sessions. Participants will be asked to complete up to 6 sessions. Passing a hearing assessment using standard audiological procedures, conducted at the start of the first session, is a requirement for participation. The experimental sessions involve behavior and non-invasive brain imaging. Investigators will ask participants to perform several short tasks to measure different aspects of their speech production and speech perception (e.g., reading passages or words aloud, making judgements about sounds). In one session, Investigators will measure electroencephalography (EEG) while participants complete tasks involving producing and hearing speech sounds. Participants will be fitted with an elastic cap and up to 32 non-invasive recording electrodes. In other sessions, investigators will measure structural and functional magnetic resonance imaging (fMRI). Structural images demonstrate the unique brain anatomy of the participant. Functional images will be obtained while the participant completes specific tasks involving listening, speaking, or completing other motor actions (e.g., pressing a button). All participants will be screened for MRI risk factors prior to each session.

Interventions

BEHAVIORALNeural responses to speech functional localizer

Measuring speech-related brain activity using fMRI during a speech listening task.

BEHAVIORALNeural responses to silent articulation

Measuring speech-related brain activity using fMRI during a silent articulation task.

BEHAVIORALNeural responses to self vs. externally generated speech

Measuring speech-related brain activity using fMRI during self-generated vs. externally-generated speech.

BEHAVIORALEvent-related potentials for speech

Measuring electroencephalography (EEG) based evoked potentials for self vs. externally generated speech

BEHAVIORALNeural responses to induced speech errors

Measuring speech-related brain activity using fMRI during conditions that induce auditory speech errors.

BEHAVIORALNeural responses to sensory-motor adaptation

Measuring brain activity using fMRI during a learning task with sustained altered auditory feedback.

BEHAVIORALSpeech production behaviors

Behavioral measurements of speech during reading passages and words

BEHAVIORALAuditory acuity testing

Measurements of auditory acuity during listening tasks.

BEHAVIORALNeural responses to learning a non-speech auditory motor behavior

Mapping of brain areas using fMRI during learning of non-speech sound-evoking movements.

Sponsors

University of Pittsburgh
Lead SponsorOTHER
Northwestern University
CollaboratorOTHER
National Institute on Deafness and Other Communication Disorders (NIDCD)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

The single group model involves assessing the neural basis of multiple behavioral tasks in three cohorts. Cohort 1 is neurotypical adults. Cohort 2 is people with post-stroke cerebellar lesions. Cohort 3 is a group of control participants that will be matched to Cohort 2. The behavioral interventions are overlapping between cohorts, though Cohort 1 will complete additional sessions.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Cohort 1 (neurotypical adults): * Age 18-49 * Right-handed * Native English speaker Cohort 2 (people with cerebellar lesions): * Age 18 or older * Right-handed * Native English speaker * History of cerebellar stroke Cohort 3 (controls matched to Cohort 2) * Age 18 or older * Right-handed * Native English speaker

Exclusion criteria

Cohort 1 (neurotypical adults): * Presence of MRI risk factors: metal and/or electromagnetic devices (e.g., pacemakers, neurostimulators) in the body, previous shrapnel injuries, use of an intrauterine device containing metal, claustrophobia, pregnant or possibly pregnant * History of neurological / neurodegenerative disease or severe brain injury (e.g., stroke or severe traumatic brain injury) * Hearing loss, defined by pure tone thresholds \>25 decibels (dB) hearing level (HL) at octave frequencies between 250-8000 Hz * Clinical diagnosis and/or treatment for schizophrenia or other psychotic disorders * Clinical diagnosis and/or treatment for neurocognitive disorders (e.g., dementia, delirium) * Presence of a severe and unmanaged, clinically diagnosed attention disorder * Clinically diagnosed with or treated for a speech, language, or hearing disorder * Head circumference greater than 60cm or weight greater than 300 pounds * History of severe claustrophobia * Currently pregnant Cohort 2 (people with cerebellar lesions): * Presence of MRI risk factors: metal and/or electromagnetic devices (e.g., pacemakers, neurostimulators) in the body, previous shrapnel injuries, use of an intrauterine device containing metal, claustrophobia, pregnant or possibly pregnant * History of neurological / neurodegenerative disease or severe brain injury other than stroke * Hearing loss, defined by pure tone thresholds \>50 dB HL at octave frequencies between 250-4000 Hz * Clinical diagnosis and/or treatment for schizophrenia or other psychotic disorders * Clinical diagnosis and/or treatment for neurocognitive disorders (e.g., dementia, delirium) * Presence of a severe and unmanaged, clinically diagnosed attention disorder * Head circumference greater than 60cm or weight greater than 300 pounds * History of severe claustrophobia * Currently pregnant Cohort 3 (controls matched to Cohort 2): * Presence of MRI risk factors: metal and/or electromagnetic devices (e.g., pacemakers, neurostimulators) in the body, previous shrapnel injuries, use of an intrauterine device containing metal, claustrophobia, pregnant or possibly pregnant * History of neurological / neurodegenerative disease or severe brain injury (e.g., stroke or severe traumatic brain injury) * Hearing loss, defined by pure tone thresholds \>50 dB HL at octave frequencies between 250-4000 Hz * Clinical diagnosis and/or treatment for schizophrenia or other psychotic disorders * Clinical diagnosis and/or treatment for neurocognitive disorders (e.g., dementia, delirium) * Presence of a severe and unmanaged, clinically diagnosed attention disorder * Clinically diagnosed with or treated for a speech, language, or hearing disorder * Head circumference greater than 60cm or weight greater than 300 pounds * History of severe claustrophobia * Currently pregnant

Design outcomes

Primary

MeasureTime frameDescription
Blood oxygenation level dependent (BOLD) responses to self vs. externally generated speechOne session lasting 2-3 hours, within 12 months of enrollmentThe dependent variables (across voxels) are blood oxygenated level dependent fMRI measurements made during task performance. We will contrast measured activations in regions of interest for the LISTEN-SELF vs. PRODUCE and LISTEN-OTHER vs. PRODUCE conditions. Encoding models will predict activity in regions-of-interest (ROIs) based on a set of speech features.
BOLD responses related to pre-speech auditory modulationOne session lasting 2-3 hours, within 12 months of enrollmentThe dependent variables (across voxels) are blood oxygenated level dependent fMRI measurements made during task performance. We will contrast measured activations in regions of interest for responses to auditory stimuli across conditions (e.g., SPEAK, REHEARSE, PLAN, SILENT).
EEG responses to self vs. externally generated speechOne session lasting 2-3 hours, within 12 months of enrollmentThe dependent variables are evoked responses, aligned to sound onset, measured with EEG during task performance. We will contrast evoked responses across conditions (e.g., TALK, LISTEN).
BOLD responses to induced auditory errorsOne session lasting 2-3 hours, within 12 months of enrollmentThe dependent variables (across voxels) are blood oxygenated level dependent fMRI measurements made during task performance. We will determine activations in regions of interest that correlate with applied perturbations during speech. We will also compare SPEAK vs. LISTEN activations in perturbed and unperturbed conditions.
BOLD responses during adaptation to auditory perturbationsOne session lasting 2-3 hours, within 12 months of enrollmentThe dependent variables (across voxels) are blood oxygenated level dependent fMRI measurements made during task performance. We will contrast measured activations in regions of interest for responses during the HOLD and BASELINE phases of the adaptation paradigm. We will determine areas where activation is associated with changes in formant frequencies in early and late windows in speech recordings.
BOLD responses during learning of non-speech auditory motor targetsOne session lasting 2-3 hours, within 12 months of enrollmentThe dependent variables (across voxels) are blood oxygenated level dependent fMRI measurements made during task performance. We will contrast measured activations in regions of interest for responses during PRESS trials across runs. We will contrast LISTEN vs. PRESS trials to measure motor induced sensory modulation.

Secondary

MeasureTime frameDescription
BOLD responses to speech listening taskOne session lasting 2-3 hours, within 12 months of enrollmentThe dependent variables (across voxels) are blood oxygenated level dependent fMRI measurements made during task performance. We will contrast measured activations for the SPEECH vs. signal correlated noise (SCN) and SPEECH vs. SILENT conditions.
BOLD responses to silent articulation taskOne session lasting 2-3 hours, within 12 months of enrollmentThe dependent variables (across voxels) are blood oxygenated level dependent fMRI measurements made during task performance. We will contrast measured activations for silent articulation vs. a resting baseline condition.
Speech formant frequenciesFirst session lasting 2-3 hours, within 12 months of enrollmentWe will measure participant-specific phonetic variables (formant frequencies) based on participant speech from reading passages and word production.
Spontaneous Speech Synchronization IndexFirst session lasting 2-3 hours, within 12 months of enrollmentWe will measure the Spontaneous Speech Synchronization Index based on behavioral speech data.
Auditory acuityFirst session lasting 2-3 hours, within 12 months of enrollmentWe will measure auditory acuity (just noticeable difference) for changes in formant frequencies based on behavioral speech samples.

Countries

United States

Contacts

CONTACTJason W Bohland, Ph.D.
j.bohland@pitt.edu412-383-3416
CONTACTAlexander Ocampo, B.A.
amo104@pitt.edu
PRINCIPAL_INVESTIGATORJason W Bohland, Ph.D.

University of Pittsburgh

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 19, 2026